Prf1−/− × PD-1−/− thymocyte recipients all developed autoimmune disease between days 13 and 21 post-transfer, while the PD-1−/− thymocyte recipients had a relatively slightly delayed course of disease (Figure 4A, p = 0.01). The gene discussed is PRF1; the disease is autoimmune disease.